References
Brown IAM, Diederich L, Good ME, DeLalio LJ, Murphy SA, Cortese-Krott
MM, et al. (2018). Vascular Smooth Muscle Remodeling in
Conductive and Resistance Arteries in Hypertension.Arteriosclerosis, thrombosis, and vascular biology 38:1969-1985.
Cai W, Zhang J, Yang J, Fan Z, Liu X, Gao W, et al. (2019).
MicroRNA-24 attenuates vascular remodeling in diabetic rats through
PI3K/Akt signaling pathway. Nutrition, metabolism, and
cardiovascular diseases : NMCD 29: 621-632.
Chen WJ, Chen YH, Hsu YJ, Lin KH, Yeh YH (2018a). MicroRNA-132 targeting
PTEN contributes to cilostazol-promoted vascular smooth muscle cell
differentiation. Atherosclerosis 274: 1-7.
Chen Z, Wang M, Huang K, He Q, Li H, Chang G (2018b). MicroRNA-125b
Affects Vascular Smooth Muscle Cell Function by Targeting Serum Response
Factor. Cellular physiology and biochemistry : international
journal of experimental cellular physiology, biochemistry, and
pharmacology 46: 1566-1580.
Chiang MH, Liang CJ, Lin LC, Yang YF, Huang CC, Chen YH, et al.(2020). miR-26a attenuates cardiac apoptosis and fibrosis by targeting
ataxia-telangiectasia mutated in myocardial infarction. Journal of
cellular physiology .
Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz
MA, et al. (2018). Experimental design and analysis and their
reporting II: updated and simplified guidance for authors and peer
reviewers. British journal of pharmacology 175: 987-993.
Dai X, Chen C, Yang Q, Xue J, Chen X, Sun B, et al. (2018).
Exosomal circRNA_100284 from arsenite-transformed cells, via
microRNA-217 regulation of EZH2, is involved in the malignant
transformation of human hepatic cells by accelerating the cell cycle and
promoting cell proliferation. Cell death & disease 9:454.
Das S, Zhang E, Senapati P, Amaram V, Reddy MA, Stapleton K, et
al. (2018). A Novel Angiotensin II-Induced Long Noncoding RNA Giver
Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular
Smooth Muscle Cells. Circulation research 123:1298-1312.
Deniset JF, Hedley TE, Hlavackova M, Chahine MN, Dibrov E, O’Hara
K, et al. (2018). Heat shock protein 60 involvement in vascular
smooth muscle cell proliferation. Cellular signalling47: 44-51.
Gul A, Leyland-Jones B, Dey N, De P (2018). A combination of the PI3K
pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine
resistance in hormone receptor-positive breast cancer: a genomic
algorithm-based treatment approach. American journal of cancer
research 8: 2359-2376.
Hayashi K, Naiki T (2009). Adaptation and remodeling of vascular wall;
biomechanical response to hypertension. Journal of the mechanical
behavior of biomedical materials 2: 3-19.
He F, Chu JF, Chen HW, Lin W, Lin S, Chen YQ, et al. (2019).
Qingxuan Jiangya Decoction () Prevents Blood Pressure Elevation and
Ameliorates Vascular Structural Remodeling via Modulating TGF- beta
1/Smad Pathway in Spontaneously Hypertensive Rats. Chinese journal
of integrative medicine .
Henn D, Abu-Halima M, Wermke D, Falkner F, Thomas B, Kopple C, et
al. (2019). MicroRNA-regulated pathways of flow-stimulated angiogenesis
and vascular remodeling in vivo. Journal of translational
medicine 17: 22.
Jiang H, Chen Y, Yu T, Zhao X, Shan H, Sun J, et al. (2018).
Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the
miR-26a/smad2 loop. American journal of physiology. Lung cellular
and molecular physiology 315: L563-l575.
Karimian A, Ahmadi Y, Yousefi B (2016). Multiple functions of p21 in
cell cycle, apoptosis and transcriptional regulation after DNA damage.DNA repair 42: 63-71.
Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of
microRNA biogenesis, function and decay. Nature reviews. Genetics11: 597-610.
Lee TH, Sottile J, Chiang HY (2015). Collagen inhibitory peptide R1R2
mediates vascular remodeling by decreasing inflammation and smooth
muscle cell activation. PloS one 10: e0117356.
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel
L, et al. (2011). MicroRNA-26a is a novel regulator of vascular
smooth muscle cell function. Journal of cellular physiology226: 1035-1043.
Lemarie CA, Tharaux PL, Lehoux S (2010). Extracellular matrix
alterations in hypertensive vascular remodeling. Journal of
molecular and cellular cardiology 48: 433-439.
Li C, Chen X, Huang J, Sun Q, Wang L (2015). Clinical impact of
circulating miR-26a, miR-191, and miR-208b in plasma of patients with
acute myocardial infarction. European journal of medical research20: 58.
Li C, Zhen G, Chai Y, Xie L, Crane JL, Farber E, et al. (2016).
RhoA determines lineage fate of mesenchymal stem cells by modulating
CTGF-VEGF complex in extracellular matrix. Nature communications7: 11455.
Li Z, Yu D, Li H, Lv Y, Li S (2019). Long noncoding RNA UCA1 confers
tamoxifen resistance in breast cancer endocrinotherapy through
regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.International journal of oncology 54: 1033-1042.
Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y, et al. (2014). The
antifibrotic effects and mechanisms of microRNA-26a action in idiopathic
pulmonary fibrosis. Molecular therapy : the journal of the
American Society of Gene Therapy 22: 1122-1133.
Liu J, Li X, Wang M, Xiao G, Yang G, Wang H, et al. (2018). A
miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in
ER-positive breast cancer. International journal of oncology53: 1601-1612.
Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, et al. (2011).
MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal
carcinoma through repression of EZH2. Cancer research71: 225-233.
Lu QB, Wang HP, Tang ZH, Cheng H, Du Q, Wang YB, et al. (2018).
Nesfatin-1 functions as a switch for phenotype transformation and
proliferation of VSMCs in hypertensive vascular remodeling.Biochimica et biophysica acta. Molecular basis of disease1864: 2154-2168.
Magnussen CG (2017). Carotid artery intima-media thickness and
hypertensive heart disease: a short review. Clinical hypertension23: 7.
Mulvany MJ (2012). Small artery remodelling in hypertension. Basic
& clinical pharmacology & toxicology 110: 49-55.
Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES (2018).
Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by
Regulating Cyclin D2. Journal of virology 92.
Peng J, He X, Zhang L, Liu P (2018). MicroRNA26a protects vascular
smooth muscle cells against H2O2induced injury through activation of the
PTEN/AKT/mTOR pathway. International journal of molecular
medicine 42: 1367-1378.
Petrosino JM, Leask A, Accornero F (2019). Genetic manipulation of
CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured
skeletal muscle. FASEB journal : official publication of the
Federation of American Societies for Experimental Biology 33:2047-2057.
Ricard-Blum S, Vallet SD (2019). Fragments generated upon extracellular
matrix remodeling: Biological regulators and potential drugs.Matrix biology : journal of the International Society for Matrix
Biology 75-76: 170-189.
Sysol JR, Chen J, Singla S, Zhao S, Comhair S, Natarajan V, et
al. (2018). Micro-RNA-1 is decreased by hypoxia and contributes to the
development of pulmonary vascular remodeling via regulation of
sphingosine kinase 1. American journal of physiology. Lung
cellular and molecular physiology 314: L461-l472.
Tan J, Yang L, Liu C, Yan Z (2017). MicroRNA-26a targets MAPK6 to
inhibit smooth muscle cell proliferation and vein graft neointimal
hyperplasia. Scientific reports 7: 46602.
Wang D, Atanasov AG (2019a). The microRNAs Regulating Vascular Smooth
Muscle Cell Proliferation: A Minireview. International journal of
molecular sciences 20.
Wang J, Zhang C, Li C, Zhao D, Li S, Ma L, et al. (2019b).
MicroRNA-92a promotes vascular smooth muscle cell proliferation and
migration through the ROCK/MLCK signalling pathway. Journal of
cellular and molecular medicine 23: 3696-3710.
Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, et al.(2013). NF-kappaB mediated miR-26a regulation in cardiac fibrosis.Journal of cellular physiology 228: 1433-1442.
Xu HM, Sui FH, Sun MH, Guo GL (2019). Downregulated microRNA-224
aggravates vulnerable atherosclerotic plaques and vascular remodeling in
acute coronary syndrome through activation of the TGF-beta/Smad pathway.Journal of cellular physiology 234: 2537-2551.
Yang X, Niu X, Xiao Y, Lin K, Chen X (2018). MiRNA expression profiles
in healthy OSAHS and OSAHS with arterial hypertension: potential
diagnostic and early warning markers. Respiratory research19: 194.
Zhang CJ, Shi YN, Liao DF, Du K, Qin L (2019). [Molecular mechanism of
vascular remodeling in hypertension and Chinese medicine
intervention]. Sheng li xue bao : [Acta physiologica
Sinica] 71: 235-247.
Zhang S, Cui R (2018). The targeted regulation of miR-26a on
PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial
infarction. European review for medical and pharmacological
sciences 22: 523-531.
Zhou J, Ju WQ, Yuan XP, Zhu XF, Wang DP, He XS (2016). miR-26a regulates
mouse hepatocyte proliferation via directly targeting the 3’
untranslated region of CCND2 and CCNE2. Hepatobiliary &
pancreatic diseases international : HBPD INT 15: 65-72.